NDC product
Articaine Hydrochloride and Epinephrine
NDC 0404-6620 · Henry Schein
Key facts
| Product NDC | 0404-6620 |
|---|---|
| Proprietary name | Articaine Hydrochloride and Epinephrine |
| Nonproprietary name | Articaine Hydrochloride and Epinephrine |
| Substances | ARTICAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE |
| Dosage form | INJECTION, SOLUTION |
| Route | SUBMUCOSAL |
| Labeler | Henry Schein |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA020971 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS] and 3 more |
| Marketing start | Jan 28, 2015 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: